Literature DB >> 22338047

Understanding and recognizing the Pelger-Huët anomaly.

Rita Colella1, Sandra C Hollensead.   

Abstract

The Pelger-Huët anomaly (PHA) is a recognized morphologic variant affecting all granulocytes but is most evident in polymorphonuclear neutrophils (PMNs). PHA is caused by a decreased amount of the lamin B receptor (LBR). Recognition of PHA morphologic features serves as a marker for mutations in the LBR gene. This review summarizes the history of PHA and the current knowledge of the functions of the LBR. Guidance is given for distinguishing PHA from other hematologic disorders in which granulocytes may show similar changes. Recognition of PHA in the laboratory should prompt communication to the patient's physician about the possible clinical significance of this finding and the recommended screening for the anomaly in other family members by CBC and review of a peripheral blood smear.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22338047     DOI: 10.1309/AJCP3G8MDUXYSCID

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Stodtmeister Cells (Polymorphs with Pelger-Huët Anomaly) Showing "Faggots" in Mixed Phenotypic Acute Leukemia (T/Myeloid).

Authors:  Tushar Sehgal; Pawan Singh; Esha Kaul
Journal:  Indian J Hematol Blood Transfus       Date:  2017-04-03       Impact factor: 0.900

Review 2.  Practical murine hematopathology: a comparative review and implications for research.

Authors:  Karyn E O'Connell; Amy M Mikkola; Aaron M Stepanek; Andyna Vernet; Christopher D Hall; Chia C Sun; Eda Yildirim; John F Staropoli; Jeannie T Lee; Diane E Brown
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

3.  Genetic architecture of band neutrophil fraction in Iceland.

Authors:  Gudjon R Oskarsson; Magnus K Magnusson; Asmundur Oddsson; Brynjar O Jensson; Run Fridriksdottir; Gudny A Arnadottir; Hildigunnur Katrinardottir; Solvi Rognvaldsson; Gisli H Halldorsson; Gardar Sveinbjornsson; Erna V Ivarsdottir; Lilja Stefansdottir; Egil Ferkingstad; Kristjan Norland; Vinicius Tragante; Jona Saemundsdottir; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Svanhvit Sigurjonsdottir; Karen O Petursdottir; Olafur B Davidsson; Thorunn Rafnar; Hilma Holm; Isleifur Olafsson; Pall T Onundarson; Brynjar Vidarsson; Olof Sigurdardottir; Gisli Masson; Daniel F Gudbjartsson; Ingileif Jonsdottir; Gudmundur L Norddahl; Unnur Thorsteinsdottir; Patrick Sulem; Kari Stefansson
Journal:  Commun Biol       Date:  2022-06-01

4.  Pseudo-Pelger-Huët anomaly and granulocytic dysplasia associated with human granulocytic anaplasmosis.

Authors:  Sunyoung Lee; Pouya Khankhanian; Carlos Salama; Maritza Brown; Joseph Lieber
Journal:  Int J Hematol       Date:  2015-03-07       Impact factor: 2.319

5.  Pseudo Pelger-Huët anomalies as potential biomarkers for acute exposure radiation dose in rhesus macaques (Macaca mulatta).

Authors:  Joshua M Hayes; John D Olson; Yuiko Chino; J Daniel Bourland; J Mark Cline; Thomas E Johnson
Journal:  Int J Radiat Biol       Date:  2021-11-11       Impact factor: 3.352

6.  A common pathomechanism in GMAP-210- and LBR-related diseases.

Authors:  Anika Wehrle; Tomasz M Witkos; Judith C Schneider; Anselm Hoppmann; Sidney Behringer; Anna Köttgen; Mariet Elting; Jürgen Spranger; Martin Lowe; Ekkehart Lausch
Journal:  JCI Insight       Date:  2018-12-06

Review 7.  Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2013-10-07

8.  Hemophagocytic lymphohistiocytosis and pelger-huët anomaly associated with colchicine intoxication.

Authors:  Baris Malbora; Emine Polat; Sare Gulfem Akyuz
Journal:  Hematol Rep       Date:  2014-06-19

9.  Occurrence of neutrophil dysplasia in the course of severe nephrotic syndrome in a 12-year-old boy on immunosuppressive therapy: Answers.

Authors:  Lidia Hyla-Klekot; Paweł Rajwa; Andrzej Paradysz; Piotr Bryniarski
Journal:  Pediatr Nephrol       Date:  2016-06-30       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.